These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29777522)

  • 1. Impact of Insulin Degludec in Hospitalized Patients With and Without Type 2 Diabetes Requiring Parenteral/Enteral Nutrition: An Observational Study.
    Fatati G; Di Donato A; Grandone I; Menicocci P; Mirri E; Prosperini G; Scardapane M; Rossi MC; Palazzi M
    Adv Ther; 2018 Jun; 35(6):809-816. PubMed ID: 29777522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of insulin degludec versus insulin glargine on glycemic control and daily fasting blood glucose variability in insulin-naïve Japanese patients with type 2 diabetes: I'D GOT trial.
    Aso Y; Suzuki K; Chiba Y; Sato M; Fujita N; Takada Y; Murano S; Kuroda H
    Diabetes Res Clin Pract; 2017 Aug; 130():237-243. PubMed ID: 28651211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RISK FACTORS FOR HYPOGLYCEMIA IN INPATIENTS WITH TOTAL PARENTERAL NUTRITION AND TYPE 2 DIABETES: A POST HOC ANALYSIS OF THE INSUPAR STUDY.
    Olveira G; Abuín J; López R; Herranz S; García-Almeida JM; García-Malpartida K; Ferrer M; Cancer E; Luengo-Pérez LM; Álvarez J; Aragón C; Ocón MJ; García-Manzanares Á; Bretón I; Serrano-Aguayo P; Pérez-Ferre N; López-Gómez JJ; Olivares J; Arraiza C; Tejera C; Martín JD; Urioste-Fondo A; Abad ÁL; Alhambra MR; Zugasti A; Parra J; Torrejón S; Tapia MJ
    Endocr Pract; 2020 Jun; 26(6):604-611. PubMed ID: 32160049
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and Safety of Insulin Degludec for Hyperglycemia Management in Noncritical Hospitalized Patients with Diabetes: An Observational Study.
    Simioni N; Filippi A; Scardapane M; Nicolucci A; Rossi MC; Frison V
    Diabetes Ther; 2017 Aug; 8(4):941-946. PubMed ID: 28585180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of insulin degludec U100 and insulin glargine U100 in combination with meal-time bolus insulin in hospitalized patients with type 2 diabetes: an open-label, randomized controlled study.
    Suzuki J; Yamakawa T; Oba M; Nagakura J; Shigematsu E; Tamura H; Takahashi K; Okamoto Y; Sakamoto R; Shinoda M; Takano T; Kadonosono K; Terauchi Y
    Endocr J; 2019 Nov; 66(11):971-982. PubMed ID: 31270291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition from intravenous insulin to subcutaneous long-acting insulin in critical care patients on enteral or parenteral nutrition.
    Ramos A; Zapata L; Vera P; Betbese AJ; Pérez A
    Endocrinol Diabetes Nutr; 2017 Dec; 64(10):552-556. PubMed ID: 29179857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of regular versus glargine insulin in stable critical care patients receiving parenteral nutrition: a randomized controlled trial.
    Oghazian MB; Javadi MR; Radfar M; Torkamandi H; Sadeghi M; Hayatshahi A; Gholami K
    Pharmacotherapy; 2015 Feb; 35(2):148-57. PubMed ID: 25689245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Insulins in Critically Ill Patients Receiving Continuous Enteral Nutrition.
    Ni K; Hawkins RM; Smyth HL; Seggelke SA; Gibbs J; Lindsay MC; Kaizer LK; Low Wang CC
    Endocr Pract; 2024 Apr; 30(4):367-371. PubMed ID: 38307456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiency.
    Baldwin D; Zander J; Munoz C; Raghu P; DeLange-Hudec S; Lee H; Emanuele MA; Glossop V; Smallwood K; Molitch M
    Diabetes Care; 2012 Oct; 35(10):1970-4. PubMed ID: 22699288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THE MANAGEMENT OF HYPERGLYCEMIA IN NONCRITICALLY ILL HOSPITALIZED PATIENTS TREATED WITH CONTINUOUS ENTERAL OR PARENTERAL NUTRITION.
    Vennard KC; Selen DJ; Gilbert MP
    Endocr Pract; 2018 Oct; 24(10):900-906. PubMed ID: 30035626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased hypoglycemia associated with renal failure during continuous intravenous insulin infusion and specialized nutritional support.
    Dickerson RN; Hamilton LA; Connor KA; Maish GO; Croce MA; Minard G; Brown RO
    Nutrition; 2011; 27(7-8):766-72. PubMed ID: 20971617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Insulin Degludec 200 U/mL and Insulin Degludec 100 U/mL in Patients with Type 2 Diabetes (Begin: Compare).
    Bode BW; Chaykin LB; Sussman AM; Warren ML; Niemeyer M; Rabøl R; Rodbard HW
    Endocr Pract; 2014 Aug; 20(8):785-91. PubMed ID: 24518180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutrition and Hyperglycemia Management in the Inpatient Setting (Meals on Demand, Parenteral, or Enteral Nutrition).
    Drincic AT; Knezevich JT; Akkireddy P
    Curr Diab Rep; 2017 Aug; 17(8):59. PubMed ID: 28664252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin glargine in patients with severe hepato-gastroenterology diseases and hyperglycemia receiving parenteral nutrition.
    Fatati G; Mirri E; Palazzi M; Vendetti AL; Pierotti F; Weber P; Mattei R; Parillo M; Coaccioli S; Puxeddu A
    Clin Ter; 2006; 157(6):511-5. PubMed ID: 17228850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glargine Insulin Use Versus Continuous Regular Insulin in Diabetic Surgical Noncritically Ill Patients Receiving Parenteral Nutrition: Randomized Controlled Study.
    Hakeam HA; Mulia HA; Azzam A; Amin T
    JPEN J Parenter Enteral Nutr; 2017 Sep; 41(7):1110-1118. PubMed ID: 27091835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degludec is superior to glargine in terms of daily glycemic variability in people with type 1 diabetes mellitus.
    Yamamoto C; Miyoshi H; Fujiwara Y; Kameda R; Ichiyama M; Nomoto H; Kameda H; Nakamura A; Atsumi T
    Endocr J; 2016; 63(1):53-60. PubMed ID: 26522272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes-specific enteral nutrition formula in hyperglycemic, mechanically ventilated, critically ill patients: a prospective, open-label, blind-randomized, multicenter study.
    Mesejo A; Montejo-González JC; Vaquerizo-Alonso C; Lobo-Tamer G; Zabarte-Martinez M; Herrero-Meseguer JI; Acosta-Escribano J; Blesa-Malpica A; Martinez-Lozano F
    Crit Care; 2015 Nov; 19():390. PubMed ID: 26549276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of inpatient hyperglycemia beginning in the emergency department: a randomized trial using insulins aspart and detemir compared with usual care.
    Bernard JB; Munoz C; Harper J; Muriello M; Rico E; Baldwin D
    J Hosp Med; 2011 May; 6(5):279-84. PubMed ID: 21661100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USE OF A COMPUTER-GUIDED GLUCOSE MANAGEMENT SYSTEM TO IMPROVE GLYCEMIC CONTROL AND ADDRESS NATIONAL QUALITY MEASURES: A 7-YEAR, RETROSPECTIVE OBSERVATIONAL STUDY AT A TERTIARY CARE TEACHING HOSPITAL.
    Tanenberg RJ; Hardee S; Rothermel C; Drake AJ
    Endocr Pract; 2017 Mar; 23(3):331-341. PubMed ID: 27967226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing hyperglycemia and diabetes in patients receiving enteral feedings: A health system approach.
    Mabrey ME; Barton AB; Corsino L; Freeman SB; Davis ED; Bell EL; Setji TL
    Hosp Pract (1995); 2015; 43(2):74-8. PubMed ID: 25744356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.